Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.400
+0.0102.56%
Volume:180.00K
Turnover:71.37K
Market Cap:247.20M
PE:-0.81
High:0.415
Open:0.415
Low:0.365
Close:0.390
52wk High:5.490
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:3.16
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.491
ROE:-242.61%
ROA:-20.57%
PB:-2.52
PE(LYR):-0.81
PS:- -

Loading ...

Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround

Stock News
·
5 hours ago

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

Stock News
·
7 hours ago

Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030

Deep News
·
Yesterday

How Traditional Chinese Medicine Is Moving From Ancient Recipes to Evidence-Based Data

Deep News
·
Yesterday

Chengdu Easton Biopharmaceuticals Schedules Participation in Semi-Annual Innovation Drug Sector Earnings Call

Deep News
·
Sep 08

The AI Drug Discovery Sector Enters Its Value-Realization Phase, Unlocking Fresh Growth Avenues for Innovative Medicines

Deep News
·
Sep 08

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

Deep News
·
Sep 07

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

Deep News
·
Sep 07

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

Deep News
·
Sep 07

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Stock News
·
Sep 07

Sichuan Biokin Pharmaceutical to Engage Investors at Star Market Innovation Drug Sector Earnings Briefing

Deep News
·
Sep 06

Innovative Drug Indices Rally, ETFs See Inflows, CXO and Research Services Show Strong Momentum

Deep News
·
Sep 06

Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment

Stock News
·
Sep 04

China Galaxy Securities Forecasts High-Growth Prospects in Innovative Drug Sector Driven by Commercialization and Out-Licensing Deals

Stock News
·
Sep 04

Navigating the Investment Landscape Amid the Innovative Drug Surge

Deep News
·
Sep 03

CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis

Stock News
·
Sep 03

Apichope's Gout Drug Candidate Meets Primary Goal in Late-Stage China Trial

Stock News
·
Sep 03

Clinical Data Readouts Take Center Stage as Chinese Biotech Firms Surge; CSPC Pharma Climbs Over 4% While Huabao's HK Biotech ETF Holds Key Support

Deep News
·
Sep 03

Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts

Deep News
·
Sep 02

Fed's Hawkish Signal Hits Hong Kong Drug Stocks: Innovative Medicine ETFs Slide Sharply

Deep News
·
Aug 31